SPRB
Spruce Biosciences, Inc.
45.40$
-0.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -399.3% | -388.3% | -747.2% | -689.8% | -1,532.1% | -2,966.6% | -1,826.0% | – | – | – | – | – | – | |
| 0.6% | 0.6% | 0.7% | 0.7% | 1.7% | 1.3% | 0.9% | – | – | – | – | – | – | |
| 36.5% | 42.3% | 78.0% | 104.7% | 189.4% | 137.9% | 78.0% | – | – | – | – | – | – | |
| -31.7% | -86.2% | -248.3% | -228.9% | -293.0% | 265.1% | 123.0% | – | – | – | – | – | – | |
| 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | |
| 455.4% | 322.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.5% | -0.1% | -0.7% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -67.3% | -58.2% | -58.1% | – | – | – | – | – | – | |
| -13.2% | -19.1% | -11.3% | -22.7% | -67.3% | -89.7% | -59.0% | – | – | – | – | – | – | |
| 42.9% | -85.3% | -758.5% | -712.5% | -1,599.3% | -3,056.2% | -1,884.9% | – | – | – | – | – | – | |
| -399.5% | -388.3% | -747.2% | -689.8% | -1,532.1% | -2,966.6% | -1,826.0% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.